(Q44229575)

English

Rabeprazole improves health-related quality of life in patients with erosive gastroesophageal reflux disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Rabeprazole improves health-related quality of life in patients with erosive gastroesophageal reflux disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

gastroesophageal reflux disease

0 references

quality of life

1 reference

based on heuristic

inferred from title

(RS)-rabeprazole

0 references

author name string

John F Johanson

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Reshmi Siddique

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Anne M Damiano

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Leonard Jokubaitis

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Anita Murthy

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ashoke Bhattacharjya

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

2574-2578

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Health-related quality of life in primary care patients with gastroesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12452397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The benefit/risk profile of rabeprazole, a new proton-pump inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/12452397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of ranitidine on symptom relief and quality of life of patients with gastro-oesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12452397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12452397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12452397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12452397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12452397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life of patients with acute erosive reflux esophagitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12452397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of gastroesophageal reflux disease on health-related quality of life.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12452397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12452397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12452397

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1020532714664

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44229575&oldid=2206513001"